BioAge Labs | 4/A:持股变动声明(修正)-高管 Morgen Eric
BioAge Labs | 4:持股变动声明-高管 RUBIN PAUL D
BioAge Labs | 4:持股变动声明-高管 Fortney Kristen
BioAge Labs | 4:持股变动声明-高管 Morgen Eric
BioAge Labs | 4:持股变动声明-高管 GOLDSTEIN DOV A MD
BioAge Labs | 4:持股变动声明-高管 Barton Shane
BioAge Labs | SCHEDULE 13G/A:其他
BioAge Labs | SCHEDULE 13G:其他
BioAge Labs | 4:持股变动声明-高管 Barton Shane
BioAge Labs | SC 13G:超过5%持股股东披露文件-VK Services, LLC(5.0%),Vinod Khosla(5.0%)等
BioAge Labs | SC 13G:超过5%持股股东披露文件-Kristen Fortney(6.6%)
BioAge Labs | 10-Q:季度报表
BioAge Labs | 8-K:BioAge Labs公布2024年第三季度财务业绩并提供业务最新情况
BioAge Labs | SC 13G:超过5%持股股东披露文件-RA Capital Management, L.P.(6.2%),Peter Kolchinsky(6.2%)等
BioAge Labs | SC 13D:超过5%持股股东披露文件-Marc Andreessen(9.0%),Benjamin Horowitz(9.0%)等
BioAge Labs | 4:持股变动声明-董事 Pande Vijay Satyanand
BioAge Labs | 4:持股变动声明- Cormorant Asset Management, LP
BioAge Labs | SC 13D:超过5%持股股东披露文件-Dr. James I. Healy (“Healy”)(6.7%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(6.5%)等
BioAge Labs | 4:持股变动声明-董事 Pande Vijay Satyanand
BioAge Labs | 4:持股变动声明-高管 Fortney Kristen